November 2017 - Page 9 of 10

Spectrum Pharmaceuticals Announces Phase 2 Trial of Poziotinib

Last week, Spectrum Pharmaceuticals, Inc. (NASDAQ:$SSPI), announced the initiation of a Phase 2 trial of poziotinib in non-small cell lung cancer patients with Exon 20 insertion mutation in EGFR or HER2. The biotechnology company runs ... [Read]

ZCL Composites Releases Q317 Results, Here’s Everything You Need to Know

Nov 6 Jen Jiang

ZCL Composites (TSX:$ZCL) released its third quarter financial results- here is everything you need to know. While initial responses reflected disappointment, investors remain confident for ZCL’s forthcoming future such that the market for tank replacements ... [Read]

Following Shares of eCobalt Solutions Inc. In Today’s Market

Nov 6 Jen Jiang

Shares of eCobalt Solutions Inc (TSX:$ECS) are moving on volatility today -3.48% or -0.04 from the open. The TSX listed company saw a recent bid of 1.11 and 261982 shares have traded hands in the ... [Read]

Why You Shouldn’t be Fooled By SunPower Corp.’s Ostensibly Promising Q3 Results

Nov 6 Jen Jiang

Despite SunPower Corp. (NASDAQ:$SPWR) beating consensus, investors remain skeptical on the company’s profitability. Specifically, SunPower posted strong Q3 results due to earlier-than-expected completion of several projects. When it comes to project companies, however, this type ... [Read]

Xcerra Corp. VP Sells 50,000 Shares, Amidst Stagnant Shares

Nov 6 Jen Jiang

Xcerra Corp. (NASDAQ:$XCRA) have been trending negatively for the past week. Let’s take a look at the numbers. The company itself is a provider of test and handling capital equipment, interface products, test fixtures, and ... [Read]

Anavex Life Sciences Corp. Releases New Clinical Data of Investigational Alzheimer’s Drug

Nov 6 Jen Jiang

Anavex Life Sciences Corp. (NASDAQ:$AVXL) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including Alzheimer’s disease, other central nervous systems (CNS) diseases, pain and various types of ... [Read]

NRG Metals Inc. Receives C$1.4 Million from Warrant Exercises

Nov 6 Jen Jiang

NRG Metals Inc. (TSX-V:$NGZ) is pleased to announce that during the month of October, it had 10, 349, 250 warrants exercised for proceeds of $1,374,845. Additionally, the company saw 875,000 stock options granted to consultants ... [Read]

Amfil Technologies Inc. Closes Acquisition of Natural Stuff Inc., Hopes to Expand Distribution Channels

Nov 3 Jen Jiang

Amfil Technologies Inc. (OTC:$AMFE) officially released an announcement that it has closed on the acquisition of Natural Stuff Inc. in the further expansion of its distribution channel. Natural Stuff Inc. is a distributor of products ... [Read]

A Summary of Community Health Systems Inc.’s 3Q17 Operation Results

Nov 3 Jen Jiang

Community Health Systems Inc. (NYSE:$CYH) announced third quarter 2017 results- with whopping net operating revenues of $3.666 billion. Specifically, that figure is a 16.3% decrease, compared with $4.380 billion for the same period in 2016. ... [Read]

Santo Mining Corp. Closes Deal with China Crypto Firm, Shares Hike

Nov 3 Jen Jiang

Santo Mining Corp (OTC:$SANP) has finalized its deal with Chongqing Yuhuan Technology Co., Ltd. – one of China’s largest cryptocurrency mining companies also known as Canoe Pool. Under this exclusive licensing agreement, Canoe Pool will ... [Read]